A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus

Clinical trial NCT02773368 · COMPLETED

Trial details

NCT number

NCT02773368

Sponsor

Novo Nordisk A/S

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2016-05-23

Primary completion

2017-09-26

Enrollment

420

View on ClinicalTrials.gov